DAA
Signs of Promise for HCV Vaccine, But Enough?
The first study of its kind has concluded that although a novel vaccine against hepatitis C does not seem to ...
MAY 11, 2020
In Prison and Out, Untreated HCV Still Poses Burden
New York—The era of direct-acting antiviral (DAA) therapy has brought cures for hepatitis C virus to hundreds ...
APRIL 9, 2020
Navigators Speed HCV Prior Authorization Insurance Coverage
Although the prior authorization process for direct-acting antiviral agents to treat hepatitis C has become ...
MAY 6, 2019
FDA Issues Black Box Warning for HBV Reactivation
The FDA is urging DAA manufacturers to place the warning labels on their drugs.
OCTOBER 6, 2016
High Rate of Cancer Recurrence Found in Certain HCV Patients
Scientists call for close monitoring of HCV patients prescribed direct-acting antivirals, particularly for those ...
APRIL 26, 2016
